In her April Industry Insights Column for eyeforpharma, (April 6, 2014), NAI President, Rita Numerof, Ph.D., discusses rapidly evolving changes in the healthcare marketplace, and the responses they demand to the commercial model historically used by pharmaceutical companies.

Distribution of Sales and Marketing Spend Must Change focuses on the need to give market access a more prominent role in commercialization, enabling a more targeted message that will be conveyed through a smaller and increasingly technology driven sales channel.